Prostate Cancer VL

Discussion on SPARTAN: A Study of Apalutamide in Men with Non-Metastatic Castration-resistant Prostate Cancer - Thomas Keane

Details
(Length of Discussion 17 min) Dr. Thomas Keane reviews recent groundbreaking data presented at the 2018 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium focusing on the much awaiting results of the SPARTAN trial. Dr. Keane started by highlighting the SPARTAN Trial presentation by Dr. Eric Small. A Study of Apalutamide (ARN-509) in Men with Non-Metastatic Castration-r...

GayBiProstate Study: Expanding Quality of Life and Understanding Sexual Function Post Treatment - Bernard Lee

Details
(Length of Discussion: 12 min) Dr. Bernard Lee shares the background and details of the GayBiProstate Study with Dr. Alicia Morgans. He explains the GayBiProstate study was developed for a patient population which is historically under studied when it comes to quality of life. The study focuses on sexual function of gay and bisexual patients ages 18-75 with a history of prostate cancer who have re...

Maelstrom: The Metabolic Syndrome in Men - Jeannette Potts

Details
(Length of Discussion: 23 min) Dr. Jeannette Potts, a private practice physician specializing in holistic care for men suffering from chronic pelvic pain, presents the topic “Maelstrom”, and the metabolic syndrome in men. Dr. Potts speaks to the incidence of metabolic syndrome and its growth in the USA and abroad. Many unhealthy habits and abnormal health parameters are associated with MetS, which...

Seeking a Diagnosis with a Rising PSA - Jelle Barentsz

Details
(Length of discussion - 9 minutes) Dr. Jelle Barentsz provides his perspective on treating a patient with a rising PSA and is seeking diagnosis options. During this discussion held at the Radiological Society of North America (RSNA) 2017 conference, he shares that he would not recommend a 12-core systematic biopsy because it is not targeted. 40% of patients with a trans-rectal ultrasound guided (T...

IRONMAN - A Better Understanding of the Variation in Care and Treatment - Daniel George

Details
(Length of Discussion: 17 min) Daniel George, MD and Director of GU Oncology talks with Alicia Morgans, MD about the IRONMAN initiative The project stemmed from the discussion Dr. George had with Dr. Philip Kantoff, MD and Lorelei Mucci, who he worked with on the project, of what is missing in the field of advanced prostate cancer. Dr. George reflects on the number of phase 3 studies that have com...

Role of MRI in Men on Active Surveillance - Laurence Klotz

Details
(Length of Discussion: 33 min) Tom Keane hosts a discussion with Laurence Klotz on the use of MRI in the detection of significant cancer and the possibility of MRI replacing biopsies in men on active surveillance. Dr. Klotz poses the question, can MRI replace biopsies in men on active surveillance? Through an overview of clinical trial data on 12 different published studies around this hot topic i...

SpaceOAR® Hydrogel Application Video -Marcio Fagundes

Details
SpaceOAR ® System Application with Dr. Fagundes (Full Procedure) (Length of video - 10 minutes) Dr. Marcio Fagundes, Medical Director and Vice Chair at Miami Cancer Institute at Baptist Health South Florida, presents the technique to inject SpaceOAR ® or hydrogel between the prostate and the rectum via a transfer needle approach. The full procedure is demonstrated starting with pre-application pre...

Discussion on the AQUARiUS and EXCAAPE studies- Thomas Keane

Details
(Length of discussion ~ 13 minutes) Thomas Keane, MD reviews three state of the art presentations from the 2017 European Society for Medical Oncology (ESMO) meeting. Dr. Keane highlights the AQUARiUS study presented by Antoine Thiery-Vuillemin who overviewed the initial results from this patient reported outcomes (PROs) study among men receiving either abiraterone + prednisone or enzalutamide. The...

Clinical Conversation: CHAARTED, LATITUDE and STAMPEDE

Details
(Length of discussion ~ 27 minutes) Charles Ryan hosts a discussion with Alicia Morgans and Christopher Sweeney regarding data from the LATITUDE, STAMPEDE and CHAARTED trials, and the survivor endpoints for patients receiving initial androgen deprivation therapy (ADT) for metastatic prostate cancer. Specifically, discussed is the interface of these three very important studies and the many treatme...

Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? - Christopher Sweeney

Details
(Length of discussion - 26 minutes) Christopher Sweeney, MD presents on the Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? Dr. Sweeney addresses how we can cure more men from prostate cancer by taking a look at preventing relapse after definitive local therapy and radiation and hormonal therapy together vs radiation therapy alone. He reflects on the length of ti...